Cimzia 2X200 MG/ML syringe kits
Ended Awarded Last action
- Contract number
- SPE2DR26F4F0H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,989
Award facts
- Contract value 100% obligated
- $23,989.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 14, 2026, provides CIMZIA 2X200 mg/ml syringe kits to the Defense Logistics Agency (DLA) with a firm fixed price of approximately $24K and an ultimate completion date of January 15, 2026. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on a non-competitive, non-set-aside basis. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $1 billion through December 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
CIMZIA (certolizumab pegol) is a biologic immunosuppressant used to treat inflammatory conditions such as rheumatoid arthritis and Crohn's disease. The delivery of these specialty pharmaceutical products through the DLA supply chain supports the Defense Health Agency and military treatment facilities worldwide. AmerisourceBergen's extensive portfolio of federal contract awards with the DLA demonstrates the company's established capability to meet government procurement requirements for critical medical commodities across multiple therapeutic domains, positioning it as a key vendor for federal military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4F0H?
SPE2DR26F4F0H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F4F0H worth?
The government has obligated $23,989 on SPE2DR26F4F0H.
Is contract SPE2DR26F4F0H an order under another contract?
Yes. SPE2DR26F4F0H is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F0H competed?
The extent of competition for SPE2DR26F4F0H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award